ADHD in the News 2022-02-17

Higher Risk of Mortality With Autism, ADHD

"This systematic review and meta-analysis comprehensively assess for the first time, to our knowledge, the available evidence regarding the risk of mortality in persons with ASD or ADHD," the authors wrote in JAMA Pediatrics.

Iron Deficiency in Mothers With Crohn’s Disease Could Lead to ADHD in Offspring

Mother’s with inflammatory bowel disease (IBD) and iron deficiency anemia (IDA) could increase the risk of offspring attention deficit/hyperactivity disorder (ADHD), according to new research. A team, led by Nora Shero, Medical University of the Americas, identified the relationship between maternal Crohn’s disease with iron deficiency anemia and ADHD in children.

ADHD and Dyslexia: Living Well With a Double Diagnosis

Attention deficit hyperactivity disorder (ADHD) and dyslexia are two distinct conditions that can both cause reading difficulties...In addition to overlap in characteristics, it is common for people with ADHD to also have dyslexia and vice versa.1 This article will explore why these conditions often occur together, how they are diagnosed and management strategies.

A Systematic Study on Using Task Performance to Inform Treatment Planning for ADHD Youth

For a study, the researchers wanted to compile all the available evidence on the use of neuropsychological task performance as a tool for informing treatment plans for ADHD kids. The emphasis of the peer-reviewed research was on the connections between task performance and academic, social, and health outcomes and treatment responsiveness.

What is rejection sensitive dysphoria? The impact of this overlooked ADHD symptom

This hypersensitivity and (often unfounded) fear of rejection is something a lot of neurodiverse people experience, but up until five years ago, it didn’t have a name...In an article for Attention, a magazine published by ADHD charity CHADD, Dr Dodson defined rejection sensitive dysphoria as ‘a triggered, wordless emotional pain that occurs after a real or perceived loss of approval, love, or respect.’

FDA approves phase 2b/3 trial of adult ADHD treatment

The FDA has granted approval to late-stage biotech company Neurocentria Inc. to conduct a pivotal phase 2b/3 human clinical trial of its drug candidate NRCT-101SR compared with inactive placebo among adults with ADHD. Current ADHD treatments target monoamine synapses, whereas this drug candidate focuses on the novel target of glutamatergic synapses, according to a press release.

10 Tips for Helping Kids with ADHD Manage Screen Time

“Electronic usage is part of daily life and is not inherently problematic, and as with many other issues, it is an issue of moderation,” says Mary Jane Weiss, PhD, BCBA-D, LABA, of Endicott College. While screen time is associated with some benefits and some adverse side effects, it’s important for parents to examine their child’s screen use, the impact it’s having on the child, and the child’s overall behavior and well-being.